<!DOCTYPE html>
<!-- saved from url=(0083)https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm -->
<html class="" data-reactroot=""><script async="false" type="text/javascript" src="chrome-extension://fnjhmkhhmkbjkkabndcnnogagogbneec/in-page.js"></script><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><script src="./46.阿托品 - 搜狗科学百科_files/analytics.js.download" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app209.us.archive.org';v.server_ms=721;archive_analytics.send_pageview({});});</script>
<script type="text/javascript" src="./46.阿托品 - 搜狗科学百科_files/bundle-playback.js.download" charset="utf-8"></script>
<script type="text/javascript" src="./46.阿托品 - 搜狗科学百科_files/wombat.js.download" charset="utf-8"></script>
<script type="text/javascript">
  __wm.init("https://web.archive.org/web");
  __wm.wombat("https://baike.sogou.com/kexue/d10046.htm","20221028212154","https://web.archive.org/","web","/_static/",
	      "1666992114");
</script>
<link rel="stylesheet" type="text/css" href="./46.阿托品 - 搜狗科学百科_files/banner-styles.css">
<link rel="stylesheet" type="text/css" href="./46.阿托品 - 搜狗科学百科_files/iconochive.css">
<!-- End Wayback Rewrite JS Include -->
<meta name="save" content="history"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="baidu-site-verification" content="VWGb6TyYx8"><meta content="阿托品 - 搜狗科学百科" name="keywords"><meta content="搜狗科学百科是一部有着平等、协作、分享、自由理念的网络科学全书，为每一个互联网用户创造一个涵盖所有领域知识、服务的中文知识性平台。" name="description"><meta http-equiv="x-dns-prefetch-control" content="on"><meta name="server" baike="235" ip="210" env="online"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://cache.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://hhy.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://pic.baike.soso.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://ugc.qpic.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://xui.ptlogin2.qq.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://q1.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://q2.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://q3.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://q4.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://q.qlogo.cn/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://img01.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://img02.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://img03.sogoucdn.com/"><link rel="dns-prefetch" href="https://web.archive.org/web/20221028212154/https://img04.sogoucdn.com/"><link rel="Shortcut Icon" href="https://web.archive.org/web/20221028212154im_/https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link rel="Bookmark" href="https://www.sogou.com/images/logo/new/favicon.ico?v=4"><link href="./46.阿托品 - 搜狗科学百科_files/base_b849887.css" rel="stylesheet"><link href="./46.阿托品 - 搜狗科学百科_files/detail_378aed5.css" rel="stylesheet"><link href="./46.阿托品 - 搜狗科学百科_files/inviteAudit_7894507.css" rel="stylesheet"><link rel="stylesheet" href="./46.阿托品 - 搜狗科学百科_files/highlight.min.css"><title>阿托品 - 搜狗科学百科</title><style>.onekey-close {
	position: absolute;
	top: 16px;
	right: 16px;
	width: 24px;
	height: 24px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	text-indent: -999em;
	background-size: 84px;
	background-position: -63px 0;
}

.onekey-login {
	position: absolute;
	top: 16.4%;
	left: 0;
	right: 0;
	width: 100%;
}

/* .onekey-login-img {
    width: 75px;
    height: 75px;
    background: url("https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/images/sprite_wap_baike.png") no-repeat;
    background-size: 100px 91px;
    background-position: 0 0;
    background-repeat: no-repeat;
    margin: 0 auto;
} */

.onekey-login-title {
	text-align: center;
	padding-bottom: 3px;
	font-size: 21px;
	font-weight: bold;
	line-height: 30px;
	color: #000;
}

.onekey-login-txt {
	text-align: center;
	font-family: PingFangSC;
	font-size: 14px;
	line-height: 20px;
	color: #8f8f8f;
}

.onekey-login-qq,
.onekey-login-wx,
.onekey-login-phone {
	display: block;
	width: 245px;
	height: 54px;
	border-radius: 45px;
	text-align: center;

	margin: 0 auto;
	font-size: 17px;
	line-height: 24px;
	color: #000;
	/* padding: 16px 77px; */
	border-radius: 12px;
	border: solid 1px #e0e0e0;
}
.onekey-qq-content,
.onekey-vx-content,
.onekey-phone-content {
	display: inline-block;
	margin-top: 16px;
}
.onekey-qq-content {
	padding: 0 5px;
}

.onekey-login-qq {
	margin-top: 48px;
	margin-bottom: 24px;
}

.onekey-login-qq:before {
	display: inline-block;
	content: "";
	width: 20px;
	height: 20px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 80px;
	background-position: -20px 0;
	vertical-align: top;
	margin: 17px 8px 0 0;
}

.onekey-login-wx {
	margin-bottom: 24px;
}

.onekey-login-wx:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: 0 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-login-phone {
}

.onekey-login-phone:before {
	display: inline-block;
	content: "";
	width: 21px;
	height: 21px;
	background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/sprite_wap_baike_37443f3.png) no-repeat;
	background-size: 84px;
	background-position: -42px 0;
	vertical-align: top;
	margin: 17px 10px 0 0;
}

.onekey-fixed {
	z-index: 100;
	position: fixed;
	top: 0;
	bottom: 0;
	left: 0;
	right: 0;
	background: #fff;
	width: 100%;
	height: 100%;
}

.onekey-fixed.forbid {
	z-index: 100;
	position: fixed;
	top: auto;
	bottom: 68px;
	left: 9%;
	right: 0;
	background: rgba(0, 0, 0, 0.7);
	width: 82%;
	height: 43px;
	border-radius: 25px;
	color: #ffffff;
}
.onekey-login-title.forbid {
	text-align: center;
	padding-bottom: 3px;
	font-size: 14px;
	font-weight: normal;
	line-height: 30px;
	color: white;
}
</style><style>#login_mask {
  background: #000;
  opacity: 0.5;
  filter: alpha(opacity=50);
  position: fixed;
  /*fixed好像在哪个IE上有BUG，先用用*/
  left: 0;
  top: 0;
  z-index: 999;
  height: 100%;
}

#login_iframe_container {
  position: fixed;
  width: 550px;
  height: 360px;
  z-index: 1020;
  background-color: #ffffff;
}

@media screen and (max-width: 828px) {
  #login_iframe_container {
    top: 50% !important;
    left: 50% !important;
    transform: translate(-50%, -50%);
  }
}

#login_iframe_container.new-login {
  width: 550px;
  height: 360px;
  background-image: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/background_2a4a8a6.png);
}

#login_iframe_container.new-login.no-bg {
  background: #fff;
}

#login_iframe_container.new-login .login-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 30px;
  letter-spacing: 0.19px;
  color: #ffffff;
  margin-top: 62px;
}
#login_iframe_container.new-login .forbid-title {
  width: 100%;
  height: 42px;
  line-height: 42px;
  text-align: center;
  font-size: 24px;
  letter-spacing: 0.19px;
  color: #333333;
  margin-top: 150px;
}

#login_iframe_container.new-login.no-bg .login-title {
  color: #333333;
}

#login_iframe_container.new-login .login-subtitle {
  width: 100%;
  height: 18px;
  line-height: 18px;
  font-size: 13px;
  letter-spacing: 0.08px;
  color: #ffffff;
  text-align: center;
  margin-top: 9px;
  margin-bottom: 43px;
}

#login_iframe_container.new-login.no-bg .login-subtitle {
  color: #999999;
}

#login_iframe_container.new-login .login-subtitle::before {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: -5px;
}

#login_iframe_container.new-login .login-subtitle::after {
  content: '';
  display: inline-block;
  width: 10px;
  height: 1px;
  background-color: #ffffff;
  position: relative;
  top: -4px;
  left: 5px;
}

#login_iframe_container.new-login.no-bg .login-subtitle::before {
  background-color: #999999;
}

#login_iframe_container.new-login.no-bg .login-subtitle::after {
  background-color: #999999;
}

#login_iframe_container.new-login .close-btn {
  position: absolute;
  top: 20px;
  right: 20px;
  width: 12px;
  height: 12px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -59px -10px;
  background-size: 81px 91px;
  cursor: pointer;
}

#login_iframe_container.new-login .login-btn {
  width: 220px;
  height: 47px;
  border-radius: 24px;
  border: solid 1px #dddddd;
  background-color: #ffffff;
  margin: 0 auto;
  margin-top: 28px;
  position: relative;
  display: block;
}

#login_iframe_container.new-login .login-btn .login-icon {
  position: absolute;
}

#login_iframe_container.new-login .login-btn .login-text {
  width: 61px;
  height: 47px;
  line-height: 47px;
  vertical-align: middle;
  font-size: 15px;
  letter-spacing: 0.1px;
  color: #666666;
  position: absolute;
  right: 62px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-icon {
  width: 22px;
  height: 27px;
  top: 10px;
  left: 67px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -54px;
  background-size: 81px 91px;
}

#login_iframe_container.new-login .login-btn.qq-btn .login-text {
  right: 59px;
}

#login_iframe_container.new-login .login-btn.wechat-btn .login-icon {
  width: 29px;
  height: 24px;
  top: 12px;
  left: 62px;
  background: url(//web.archive.org/web/20221028205211/https://hhy.sogoucdn.com/js/common/hhy/login-sprites_e3853e5.png) -10px -10px;
  background-size: 81px 91px;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style><style>/* -- container -- */
.rodal,
.rodal-mask {
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    z-index: 100;
}

.rodal {
    position: fixed;
}

/* -- mask -- */
.rodal-mask {
    position: fixed;
    background: rgba(0, 0, 0, .5);
}

/* -- dialog -- */
.rodal-dialog {
    position: absolute;
    z-index: 101;
    background: #fff;
    border-radius: 3px;
    box-shadow: 0 1px 3px rgba(0, 0, 0, .2);
}

.rodal-center {
    top: 50%;
    transform: translateY(-50%);
    left: 0;
    right: 0;
    margin: 0 auto;
}

.rodal-bottom {
    left: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

.rodal-top {
    left: 0;
    right: 0;
    top: 0;
    margin: auto;
}

.rodal-left {
    top: 0;
    left: 0;
    bottom: 0;
    margin: auto;
}

.rodal-right {
    top: 0;
    right: 0;
    bottom: 0;
    margin: auto;
}

/* -- close button -- */
.rodal-close {
    position: absolute;
    cursor: pointer;
    top: 16px;
    right: 16px;
    width: 16px;
    height: 16px;
}

.rodal-close:before,
.rodal-close:after {
    position: absolute;
    content: '';
    height: 2px;
    width: 100%;
    top: 50%;
    left: 0;
    margin-top: -1px;
    background: #999;
    border-radius: 100%;
    -webkit-transition: background .2s;
    transition: background .2s;
}

.rodal-close:before {
    -webkit-transform: rotate(45deg);
    transform: rotate(45deg);
}

.rodal-close:after {
    -webkit-transform: rotate(-45deg);
    transform: rotate(-45deg);
}

.rodal-close:hover:before,
.rodal-close:hover:after {
    background: #333;
}

/* -- fade -- */
/* @-webkit-keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

@keyframes rodal-fade-enter {
    from {
        opacity: 0;
    }
}

.rodal-fade-enter {
    -webkit-animation: rodal-fade-enter both ease-in;
    animation: rodal-fade-enter both ease-in;
} */

@-webkit-keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

@keyframes rodal-fade-leave {
    to {
        opacity: 0
    }
}

.rodal-fade-leave {
    -webkit-animation: rodal-fade-leave both ease-out;
    animation: rodal-fade-leave both ease-out;
}

/* -- zoom -- */
@-webkit-keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-enter {
    from {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-enter {
    -webkit-animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-zoom-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

@keyframes rodal-zoom-leave {
    to {
        -webkit-transform: scale3d(.3, .3, .3);
        transform: scale3d(.3, .3, .3);
    }
}

.rodal-zoom-leave {
    -webkit-animation: rodal-zoom-leave both;
    animation: rodal-zoom-leave both;
}

/* -- slideDown -- */
@-webkit-keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-enter {
    from {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-enter {
    -webkit-animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideDown-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

@keyframes rodal-slideDown-leave {
    to {
        -webkit-transform: translate3d(0, -100px, 0);
        transform: translate3d(0, -100px, 0);
    }
}

.rodal-slideDown-leave {
    -webkit-animation: rodal-slideDown-leave both;
    animation: rodal-slideDown-leave both;
}

/* -- slideLeft -- */
@-webkit-keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-enter {
    from {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-enter {
    -webkit-animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideLeft-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

@keyframes rodal-slideLeft-leave {
    to {
        -webkit-transform: translate3d(-150px, 0, 0);
        transform: translate3d(-150px, 0, 0);
    }
}

.rodal-slideLeft-leave {
    -webkit-animation: rodal-slideLeft-leave both;
    animation: rodal-slideLeft-leave both;
}

/* -- slideRight -- */
@-webkit-keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-enter {
    from {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-enter {
    -webkit-animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-slideRight-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

@keyframes rodal-slideRight-leave {
    to {
        -webkit-transform: translate3d(150px, 0, 0);
        transform: translate3d(150px, 0, 0);
    }
}

.rodal-slideRight-leave {
    -webkit-animation: rodal-slideRight-leave both;
    animation: rodal-slideRight-leave both;
}

/* -- slideUp -- */
@-webkit-keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-enter {
    from {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-enter {
    -webkit-animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
    animation: rodal-slideUp-enter both cubic-bezier(0.23, 1, 0.32, 1);
}

@-webkit-keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

@keyframes rodal-slideUp-leave {
    to {
        -webkit-transform: translate3d(0, 100px, 0);
        transform: translate3d(0, 100px, 0);
    }
}

.rodal-slideUp-leave {
    -webkit-animation: rodal-slideUp-leave both;
    animation: rodal-slideUp-leave both;
}

/* -- flip -- */
@-webkit-keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

@keyframes rodal-flip-enter {
    from {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 60deg);
    }

    70% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }
}

.rodal-flip-enter {
    -webkit-animation: rodal-flip-enter both ease-in;
    animation: rodal-flip-enter both ease-in;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

@-webkit-keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

@keyframes rodal-flip-leave {
    from {
        -webkit-transform: perspective(400px);
        transform: perspective(400px);
    }

    30% {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
        transform: perspective(400px) rotate3d(1, 0, 0, -15deg);
    }

    to {
        -webkit-transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
        transform: perspective(400px) rotate3d(1, 0, 0, 45deg);
    }
}

.rodal-flip-leave {
    -webkit-animation: rodal-flip-leave both;
    animation: rodal-flip-leave both;
    -webkit-backface-visibility: visible !important;
    backface-visibility: visible !important;
}

/* -- rotate -- */
@-webkit-keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-enter {
    from {
        -webkit-transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, -180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-enter {
    -webkit-animation: rodal-rotate-enter both;
    animation: rodal-rotate-enter both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

@-webkit-keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

@keyframes rodal-rotate-leave {
    to {
        -webkit-transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
        transform: rotate3d(0, 0, 1, 180deg) scale3d(.3, .3, .3);
    }
}

.rodal-rotate-leave {
    -webkit-animation: rodal-rotate-leave both;
    animation: rodal-rotate-leave both;
    -webkit-transform-origin: center;
    transform-origin: center;
}

/* -- door -- */
@-webkit-keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

@keyframes rodal-door-enter {
    from {
        -webkit-transform: scale3d(0, 1, 1);
        transform: scale3d(0, 1, 1);
    }
}

.rodal-door-enter {
    -webkit-animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
    animation: rodal-door-enter both cubic-bezier(0.4, 0, 0, 1.5);
}

@-webkit-keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

@keyframes rodal-door-leave {
    60% {
        -webkit-transform: scale3d(.01, 1, 1);
        transform: scale3d(.01, 1, 1);
    }

    to {
        -webkit-transform: scale3d(0, 1, .1);
        transform: scale3d(0, 1, .1);
    }
}

.rodal-door-leave {
    -webkit-animation: rodal-door-leave both;
    animation: rodal-door-leave both;
}</style></head><body class=""><!-- BEGIN WAYBACK TOOLBAR INSERT -->
<style type="text/css">
body {
  margin-top:0 !important;
  padding-top:0 !important;
  /*min-width:800px !important;*/
}
</style>
<script>__wm.rw(0);</script>
<div id="wm-ipp-base" lang="en" style="display: block; direction: ltr;">
</div><div id="wm-ipp-print">The Wayback Machine - https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm</div>
<script type="text/javascript">//<![CDATA[
__wm.bt(675,27,25,2,"web","https://baike.sogou.com/kexue/d10046.htm","20221028212154",1996,"/_static/",["/_static/css/banner-styles.css?v=S1zqJCYt","/_static/css/iconochive.css?v=qtvMKcIJ"], false);
  __wm.rw(1);
//]]></script>
<!-- END WAYBACK TOOLBAR INSERT --><script>window._gtag=window._gtag||{};window._gtag.shouldGrayed = false;if ('10b61891764a4a6cb819de56afaa7c31') window._gtag.traceId = '10b61891764a4a6cb819de56afaa7c31';if ({"illegality":true}) window.userInfo = {"illegality":true};</script><div class="topnavbox"><ul class="topnav"><li><a href="https://web.archive.org/web/20221028212154/https://www.sogou.com/web?query=">网页</a></li><li><a href="https://web.archive.org/web/20221028212154/https://weixin.sogou.com/weixin?p=75351201">微信</a></li><li><a href="https://web.archive.org/web/20221028212154/https://zhihu.sogou.com/zhihu?p=75351218">知乎</a></li><li><a href="https://web.archive.org/web/20221028212154/https://pic.sogou.com/pics?query=">图片</a></li><li><a href="https://web.archive.org/web/20221028212154/https://v.sogou.com/v?query=">视频</a></li><li><a href="https://web.archive.org/web/20221028212154/https://mingyi.sogou.com/">医疗</a></li><li class="cur"><strong>科学</strong></li><li><a href="https://web.archive.org/web/20221028212154/https://hanyu.sogou.com/">汉语</a></li><li><a href="https://web.archive.org/web/20221028212154/https://wenwen.sogou.com/">问问</a></li><li><a href="https://web.archive.org/web/20221028212154/https://www.sogou.com/docs/more.htm">更多<span class="topraquo">»</span></a></li></ul></div><div id="header" class=""><div class="header-wrap"><a class="header-logo" href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue"></a><div class="header-search"><div class="querybox" id="suggBox"><form><input id="searchInput" class="query" type="text" placeholder="搜科学领域专业百科词条" name="query" autocomplete="off" value="" control-id="ControlID-1"><a href="javascript:;" class="query-search"></a></form></div></div><div class="header-rgt"><span class="btn-header-rgt btn-edit" id="editLemma">创建</span><div class="header-user no-login"></div></div></div></div><div class="fixed-placeholder" style="visibility:none"></div><div id="container" class=""><div class="content lemma-level1"><div class="detail-title" id="abstract-title"><h1>阿托品</h1><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#!" class="detail-edit">编辑</a></div><div class="section_content" data-id="52067579929348363"><div><p>阿托品是一种药物，用于治疗特定类型的神经毒剂和农药中毒以及某些类型的心动过缓，并减少手术期间唾液的产生。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_1" class="kx_ref">[1]</a></sup> 阿托品通常通过静脉注射或肌肉注射给药。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_1" class="kx_ref">[1]</a></sup> 用于治疗葡萄膜炎和早期弱视的时候，它的滴眼液也是可行的。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_2" class="kx_ref">[2]</a></sup> 静脉注射通常在一分钟内开始起效，药效持续半小时至1小时。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_3" class="kx_ref">[3]</a></sup> 可能需要大剂量来治疗一些中毒。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_1" class="kx_ref">[1]</a></sup> </p>
<p>阿托品常见的副作用包括口干、散瞳、尿潴留、便秘和心动过速。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_1" class="kx_ref">[1]</a></sup> 该药物一般不用于闭角型青光眼患者。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_1" class="kx_ref">[1]</a></sup> 没有证据表明在怀孕期间使用阿托品会导致出生缺陷，但是该领域还没有得到充分的研究。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_4" class="kx_ref">[4]</a></sup> 在母乳期使用阿托品是基本安全的。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_4" class="kx_ref">[4]</a></sup> 阿托品是一种抗毒蕈碱(一种抗胆碱能药)，通过抑制副交感神经系统发挥作用。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_1" class="kx_ref">[1]</a></sup> </p>
<p>阿托品天然存在于茄属植物的许多植物中，包括致命的颠茄、曼陀罗草和曼德拉草。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_5" class="kx_ref">[5]</a></sup> 1833年阿托品第一次被分离出来。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_6" class="kx_ref">[6]</a></sup> 现在它被列入世界卫生组织的基本药物清单，这些药物都是卫生系统中最有效和最安全的药物。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_7" class="kx_ref">[7]</a></sup> 阿托品是一种普通的药物，而且比较廉价，在发展中国家，一毫克的小瓶阿托品批发价格在0.06美元到0.44美元之间。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_8" class="kx_ref">[8]</a></sup> </p></div></div><div id="catalog"><h2 class="title2">目录<a href="javascript:" class="detail-edit">编辑</a></h2><div class="catalog_wrap" style=""><ul class="catalog_list col3"><li><span class="order">1</span><a href="javascript:" data-level="1" data-id="14994012352021000">医疗用途</a></li><li class="secondary_catalog"><span>1.1 </span><a href="javascript:" data-id="14994012352021000">眼睛</a></li><li class="secondary_catalog"><span>1.2 </span><a href="javascript:" data-id="14994012352021000">心脏</a></li><li class="secondary_catalog"><span>1.3 </span><a href="javascript:" data-id="14994012352021000">腺体分泌</a></li><li class="secondary_catalog"><span>1.4 </span><a href="javascript:" data-id="14994012352021000">中毒</a></li><li><span class="order">2</span><a href="javascript:" data-level="1" data-id="14994012352021001">副作用</a></li></ul><ul class="catalog_list col3"><li><span class="order">3</span><a href="javascript:" data-level="1" data-id="14994012352021002">禁忌症</a></li><li><span class="order">4</span><a href="javascript:" data-level="1" data-id="14994012352021003">化学结构</a></li><li><span class="order">5</span><a href="javascript:" data-level="1" data-id="14994012352021004">药理作用</a></li><li><span class="order">6</span><a href="javascript:" data-level="1" data-id="14994012368798214">历史发展</a></li><li><span class="order">7</span><a href="javascript:" data-level="1" data-id="14994012368798215">自然资源</a></li><li><span class="order">8</span><a href="javascript:" data-level="1" data-id="14994012385575425">综合</a></li></ul><ul class="catalog_list col3"><li class="secondary_catalog"><span>8.1 </span><a href="javascript:" data-id="14994012385575425">生物合成</a></li><li><span class="order">9</span><a href="javascript:" data-level="1" data-id="14994012385575426">姓名</a></li><li><span class="order">10</span><a href="javascript:" data-level="1" data-id="references">参考文献</a></li></ul></div></div><div id="paragraphs"><div><div id="par_14994012352021000"><h2 class="title">1 医疗用途<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p></p><h3>1.1 <span>眼睛</span></h3><p></p><p>外用阿托品用作睫状肌麻痹剂，使调节反射暂时性麻痹，并用作散瞳剂，扩张瞳孔。阿托品代谢缓慢，通常在7</p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img04.sogoucdn.com/app/a/200698/sogou_science_4365" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true" data-loaded="true" style="background-image: url(&quot;https://web.archive.org/web/20221028212154/https://img04.sogoucdn.com/app/a/200698/sogou_science_4365&quot;);"></a>
            <div class="text_img_title">一种阿托品注射液的安瓿1mL / 0.5mg。</div>   
        </div>至14天内消失，通常作为散瞳剂，而托吡卡胺(一种短效胆碱拮抗剂)或去氧肾上腺素(一种α肾上腺素激动剂)则优选用于眼科检查。<p></p><p>在屈光性和调节性弱视中，当遮挡不合适时，阿托品可能会导致好的眼睛视力模糊。有证据表明在提高视力方面，阿托品在压抑疗法和遮盖疗法有同样的功效。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_9" class="kx_ref">[9]</a></sup> </p><p>几项研究表明阿托品滴眼液能有效减缓儿童近视的发展，但目前还不能用于这种用途，副作用会限制其使用。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_10" class="kx_ref">[10]</a></sup> </p><p></p><h3>1.2 <span>心脏</span></h3><p></p><p>阿托品注射用于治疗心动过缓(心率&lt; 60次/分钟)。</p><p>阿托品曾被纳入国际复苏指南，用于与心脏衰竭和PEA相关的心脏骤停，但由于缺乏有效证据，于2010年从该指南中删除。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_11" class="kx_ref">[11]</a></sup> 对于出现症状的心动过缓，通常剂量为0.5至1毫克静脉推注，可每3至5分钟重复一次，总剂量为3毫克(最大0.04毫克/千克)。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_12" class="kx_ref">[12]</a></sup> </p><p>阿托品也可用于治疗二度莫氏1型房室传导阻滞(文氏阻滞)，以及具有高浦肯野或房室结逸搏节律的三级心脏传导阻滞。但是它对二度莫氏2型房室传导阻滞无效，对三级心脏传导阻滞伴有低浦肯野或心室逸搏节律无效。</p><p>阿托品也被用于预防儿童插管期间的心动过缓；然而，证据并不支持这种用法。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_13" class="kx_ref">[13]</a></sup> </p><p></p><h3>1.3 <span>腺体分泌</span></h3><p></p><p>阿托品通过对副交感神经系统作用抑制唾液腺和粘液腺。它还可以通过交感神经系统抑制出汗，这可以用于治疗多汗症，并可以防止垂死病人的死前喉鸣。尽管美国食品和药物管理局尚未正式指出阿托品可以用于上述用途，但医生已经为此目的开始使用阿托品。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_14" class="kx_ref">[14]</a></sup> </p><p></p><h3>1.4 <span>中毒</span></h3><p></p><p>阿托品不是有机磷中毒的真正解毒剂，但是阿托品通过阻断乙酰胆碱在M受体上的作用，可作为有机磷杀虫剂和神经毒气中毒的治疗药物，如塔崩、沙林、梭曼和VX。可能受到化学武器攻击的部队通常携带带有阿托品和肟类解毒剂的自动注射器，以便快速注射到大腿肌肉中，随着神经毒气中毒的发展，最大限度的阿托品化是可取的。使用时，阿托品经常与氯磷定一起使用。</p><p>一些神经毒剂通过磷酸化破坏乙酰胆碱酯酶，因此乙酰胆碱的作用变得过于持久，而解磷定(2-PAM)可以有效对抗有机磷中毒，因为它可以重新切断这种磷酸化。阿托品可以通过阻断M受体来降低中毒的影响，否则M受体会被乙酰胆碱的过度积累而刺激。</p></div></div><div id="par_14994012352021001"><h2 class="title">2 副作用<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>阿托品的不良反应包括心室颤动、室上性或室性心动过速、头晕、恶心、视力模糊、失去平衡、瞳孔放大、畏光、口干和潜在的严重失去意识、尤其在老年人群中，还易出现谵妄幻觉和兴奋。大多数安瓿装的阿托品都是硫酸盐的形式，阿托品的硫酸盐会导致组胺释放，并且使易感病人和对磺胺类药物过敏的病人出现过敏反应，后一种效应是因为阿托品能够穿过血脑屏障。由于存在致幻性，阿托品被一些人娱乐性质的使用，这存在着潜在的危险，而且经常引发矛盾。</p><p>过量服用阿托品是有毒的。阿托品有时被添加到潜在的成瘾性药物中，特别是止泻阿片类药物，如地芬诺酯或地芬诺辛，其中阿托品的抑制分泌作用也可有助于止泻。</p><p>虽然阿托品在紧急情况下治疗心动过缓(心率缓慢)，但当剂量非常低(即&lt; 0.5毫克)时，可能会导致反常的心率减慢<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_15" class="kx_ref">[15]</a></sup> 这可能是神经系统的中枢作用的结果。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_16" class="kx_ref">[16]</a></sup> 阿托品在低剂量时产生反常心动过缓效应的一种机制是阻断抑制性突触前M受体，从而阻断抑制副交感神经反应的系统。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_17" class="kx_ref">[17]</a></sup> </p><p>阿托品的剂量为每人10至20毫克，会使人丧失能力。它的LD50估计为每人453毫克(经口)，概率单位斜率为1.8。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_18" class="kx_ref">[18]</a></sup> 阿托品的解毒剂是毒扁豆碱或毛果芸香碱。</p><p>描述阿托品过量的临床表现常用助记法是:"热得像野兔，瞎得像蝙蝠，干得像骨头，红得像甜菜，疯得像帽匠"。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_19" class="kx_ref">[19]</a></sup> 这些联系反映了温暖干燥皮肤的特殊变化，如出汗减少、视力模糊、出汗/流泪减少、血管舒张和中枢神经系统对M受体4型和5型的影响。这一系列症状被称为抗胆碱中毒综合症，也可能由具有抗胆碱能作用的其他药物引起，如氢溴酸东莨菪碱(东莨菪碱)、苯海拉明、吩噻嗪抗精神病药物和苯妥英。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_20" class="kx_ref">[20]</a></sup> </p></div></div><div id="par_14994012352021002"><h2 class="title">3 禁忌症<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>阿托品禁用于预先治疗窄角型青光眼的患者。</p></div></div><div id="par_14994012352021003"><h2 class="title">4 化学结构<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>阿托品是D-莨菪碱和L-莨菪碱的对映体混合物，其大部分生理作用来自于L-莨菪碱。其药理作用是由于阿托品与胆碱型乙酰胆碱受体结合，它是胆碱受体阻断药。在中枢神经系统中，药物浓度在30分钟至1小时内达到显著水平，然后迅速从血液中消失，半衰期为2小时。大约60%在尿液中以原型排出，其余大部分以水解和耦合产物的形式出现在尿液中。去甲阿托品(24%)、阿托品-氮氧化物(15%)、托品(2%)和托品酸(3%)是主要代谢物，而50%的服药量没有明显改变被排出，排出物没有检测到耦合产物。有证据发现阿托品以(+)-莨菪碱形式存在，这表明阿托品可能发生立体选择性代谢。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_21" class="kx_ref">[21]</a></sup> 阿托品对虹膜和睫状肌的影响可能持续超过72小时。</p><p>药物中最常见的阿托品化合物是硫酸阿托品(一水合物)(C17H23NO3)2 H2SO4 H2O，全称是1α H，5αH-托品-3-α醇()-托品酯(酯)，硫酸盐一水合物。</p></div></div><div id="par_14994012352021004"><h2 class="title">5 药理作用<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>一般来说，阿托品拮抗副交感神经系统调节的腺体的“休息和消化”活动。这是因为阿托品是胆碱型乙酰胆碱受体(乙酰胆碱是副交感神经系统的主要神经递质)的竞争性可逆拮抗剂。</p><p>阿托品是胆碱型乙酰胆碱受体类型M1、M2、M3、M4和M5的竞争性拮抗剂。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_22" class="kx_ref">[22]</a></sup> 它被归类为胆碱受体阻断药(副交感神经阻断药)。</p><p>在心脏应用中，它作为非选择性胆碱型乙酰胆碱拮抗剂发挥作用，增加窦房结的触发和通过心脏房室结的传导，拮抗迷走神经的作用，阻断乙酰胆碱受体位点，并减少支气管分泌物。</p><p>在眼部，阿托品通过阻断圆形瞳孔括约肌收缩产生散瞳作用，进而使桡动脉虹膜扩张肌收缩并散瞳，圆形瞳孔括约肌通常是乙酰胆碱释放产生刺激作用。阿托品可以麻痹睫状肌，睫状肌的作用是抑制儿童进行精确屈光调节，有助于减轻虹膜睫状体炎相关的疼痛，并治疗睫状体阻塞(恶性)青光眼。</p><p>迷走神经释放乙酰胆碱作为心脏的主要神经递质，乙酰胆碱与M受体(M2)结合，M受体主要存在于窦房结和房室结细胞中，而M受体与Gi蛋白偶联；因此，迷走神经激活降低了cAMP（环磷酸腺苷）。Gi蛋白激活也导致钾离子通道的激活，增加钾离子的流出并使细胞超极化。</p><p>迷走神经对窦房结活动的增加降低了起搏电位的斜率(动作电位的第4阶段)同时也降低起搏细胞的放电率，也降低了心率(负心律变率性)。阶段4斜率的变化是由钾离子电流和钙离子电流的变化，以及缓慢内流的钠离子电流，它被认为是起搏电流产生的原因。通过使细胞超极化，迷走神经的活化增加了细胞的放电阈值，这有助于降低放电速率。房室结也有类似的电生理效应；然而，在这种组织中，这些变化表现为通过房室结的脉冲传导速度降低(负向单向传导)。在静息状态下，心脏有很大程度的迷走神经张力，这是静息心率低的原因。</p><p>心房肌肉也有一些迷走神经的神经支配，心室肌肉则更少。因此，迷走神经活化导致心房收缩力(收缩力)的适度降低，甚至心室收缩力的更小的降低。</p><p>M受体拮抗剂结合M受体，从而防止ACh结合并激活受体。M受体拮抗剂通过阻断ACh的作用，非常有效地阻断迷走神经活动对心脏的影响。通过这样，他们增加了心率和传导速度。</p></div></div><div id="par_14994012368798214"><h2 class="title">6 历史发展<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img02.sogoucdn.com/app/a/200698/sogou_science_4366" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true"></a>
            <div class="text_img_title" style="text-align: center;">颠茄</div>   
        </div> <p></p><p>曼陀罗(曼德拉草)在公元前四世纪被提奥夫拉斯图斯记录为治疗伤口、痛风和失眠的药物，以及爱情药剂。到公元一世纪，迪奥斯科林斯认为曼德拉草酒是一种麻醉剂，用于治疗疼痛或失眠，在手术或烧灼术之前服用。含有托烷生物碱的茄科经常与鸦片结合用于麻醉，在整个罗马帝国和伊斯兰帝国时期一直存在，并在欧洲也持续存在，直到被乙醚、氯仿和其他现代麻醉剂所取代。</p><p>埃及克娄巴特拉在公元前最后一个世纪使用埃及天仙子中提取的阿托品扩大她的瞳孔，希望她看起来更有魅力。在文艺复兴时期，出于对美丽的原因，女性使用阿特拉巴贝拉当纳的浆果汁来扩大她们的瞳孔。这种做法在十九世纪末二十世纪初在巴黎曾短暂地恢复。</p><p>德国化学家弗里德利布·费迪南·龙格(1795-1867)研究了阿托品的散瞳效应。1831年，德国药剂师海因里希·梅因(1799-1864)<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_23" class="kx_ref">[23]</a></sup> 成功地制备出阿托品晶体。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_24" class="kx_ref">[24]</a></sup> <sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_25" class="kx_ref">[25]</a></sup> 1901年，德国化学家理查德·威尔斯特首次合成了这种物质。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_26" class="kx_ref">[26]</a></sup> </p></div></div><div id="par_14994012368798215"><h2 class="title">7 自然资源<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>阿托品存在于茄科的许多成员中。最常见的来源是颠茄、曼陀罗、金雀花和曼陀罗。其他来源包括木曼陀罗属和天仙子属的成员。</p></div></div><div id="par_14994012385575425"><h2 class="title">8 综合<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>阿托品可以在盐酸存在下由莨菪碱与托品酸反应合成。</p><p></p><h3>8.1 <span>生物合成</span></h3><p></p><p></p><div class="text_img ed_imgfloat_right">
            <a class="ed_image_link lazyLoad" data-src="https://img03.sogoucdn.com/app/a/200698/sogou_science_4367" data-bigsrc="" title="点击查看大图" href="javascript:" data-observer="true"></a>
            <div class="text_img_title" style="text-align: center;">以L-苯丙氨酸为起始原料合成阿托品</div>   
        </div> <p></p><p>从l-苯丙氨酸开始的阿托品生物合成首先经历转氨作用，形成苯丙酮酸，然后被还原成苯乳酸。辅酶a然后将苯基乳酸与托品偶联形成利特林，然后托品经历由P450酶引发的自由基重排形成天仙子胺醛。脱氢酶随后将醛还原成伯醇，生成()-天仙子胺，在外消旋化时形成阿托品。<sup><a href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/d10046.htm#quote_27" class="kx_ref">[27]</a></sup> </p></div></div><div id="par_14994012385575426"><h2 class="title">9 姓名<a href="javascript:" class="detail-edit">编辑</a></h2><div class="section_content"><p>物种名称“颠茄”(意大利语中的“美丽女人”)来源于最初使用的茄属植物来扩张瞳孔以达到美容效果。阿托品和颠茄的属名都来源于阿特洛波斯，根据希腊神话，他是选择一个人死亡方式的命运三神之一。</p></div></div></div></div><div id="references"><h2 class="title" id="par_references">参考文献</h2><ul class="references"><li id="quote_1"><span class="references-num">[1]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Atropine". The American Society of Health-System Pharmacists. Archived from the original on 2015-07-12. Retrieved Aug 13, 2015..</span></p></li><li id="quote_2"><span class="references-num">[2]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">design, Richard J. Hamilton ; Nancy Anastasi Duffy, executive editor ; Daniel Stone, production editor ; Anne Spencer, cover (2014). Tarascon pharmacopoeia (15 ed.). p. 386. ISBN 9781284056716. Archived from the original on 2015-10-02..</span></p></li><li id="quote_3"><span class="references-num">[3]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Barash, Paul G. (2009). Clinical anesthesia (6th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams &amp; Wilkins. p. 525. ISBN 9780781787635. Archived from the original on 2015-11-24..</span></p></li><li id="quote_4"><span class="references-num">[4]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Atropine Pregnancy and Breastfeeding Warnings". Archived from the original on 6 September 2015. Retrieved 14 August 2015..</span></p></li><li id="quote_5"><span class="references-num">[5]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Brust,, John C. M. (2004). Neurological aspects of substance abuse (2 ed.). Philadelphia: Elsevier. p. 310. ISBN 9780750673136. Archived from the original on 2015-10-02..</span></p></li><li id="quote_6"><span class="references-num">[6]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Ainsworth, Sean (2014). Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. John Wiley &amp; Sons. p. 94. ISBN 9781118819593. Archived from the original on 2015-10-02..</span></p></li><li id="quote_7"><span class="references-num">[7]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016..</span></p></li><li id="quote_8"><span class="references-num">[8]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Atropine Sulfate". International Drug Price Indicator Guide. Retrieved 13 August 2015..</span></p></li><li id="quote_9"><span class="references-num">[9]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Li T, Shotton K (2009). "Conventional occlusion versus pharmacologic penalization for amblyopia". Cochrane Database Syst Rev. 4: CD006460. doi:10.1002/14651858.CD006460.pub2. PMC 3804306. PMID 19821369..</span></p></li><li id="quote_10"><span class="references-num">[10]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD (2011). "Interventions to slow progression of myopia in children". Cochrane Database Syst Rev (12): CD004916. doi:10.1002/14651858.CD004916.pub3. PMC 4270373. PMID 22161388..</span></p></li><li id="quote_11"><span class="references-num">[11]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Field JM, Hazinski MF, Sayre MR, et al. (November 2010). "Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 122 (18 Suppl 3): S640–56. doi:10.1161/CIRCULATIONAHA.110.970889. PMID 20956217. Archived from the original on 2010-11-14..</span></p></li><li id="quote_12"><span class="references-num">[12]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">* Bryan E, Bledsoe; Robert S. Porter; Richard A. Cherry (2004). "Ch. 3". Intermediate Emergency Care. Upper Saddle River, NJ: Pearson Prentice Hill. p. 260. ISBN 0-13-113607-0..</span></p></li><li id="quote_13"><span class="references-num">[13]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">de Caen, AR; Berg, MD; Chameides, L; Gooden, CK; Hickey, RW; Scott, HF; Sutton, RM; Tijssen, JA; Topjian, A; van der Jagt, ÉW; Schexnayder, SM; Samson, RA (3 November 2015). "Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care" (PDF). Circulation. 132 (18 Suppl 2): S526–42. doi:10.1161/cir.0000000000000266. PMID 26473000..</span></p></li><li id="quote_14"><span class="references-num">[14]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Death Rattle and Oral Secretions Archived 2014-04-14 at the Wayback Machine.</span></p></li><li id="quote_15"><span class="references-num">[15]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">"Archived copy". Archived from the original on 2014-02-20. Retrieved 2014-02-02.CS1 maint: Archived copy as title (link).</span></p></li><li id="quote_16"><span class="references-num">[16]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">* Rang HP, Dale MM, Ritter JM, Flower RJ (2007). "Ch. 10". Rang and Dale's Pharmacology. Elsevier Churchill Livingstone. p. 153. ISBN 0-443-06911-5..</span></p></li><li id="quote_17"><span class="references-num">[17]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Laurence, Brunton (2010). Goodman &amp; Gilman's Pharmacological Basis of Therapeutics, 12th Edition. McGraw-Hill. ISBN 978-0-07-162442-8..</span></p></li><li id="quote_18"><span class="references-num">[18]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">* Goodman E (2010). Ketchum J, Kirby R, eds. Historical Contributions to the Human Toxicology of Atropine. Eximdyne. p. 120. ISBN 978-0-9677264-3-4..</span></p></li><li id="quote_19"><span class="references-num">[19]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Robert S. Holzman, MD (July 1998). "The Legacy of Atropos". Anesthesiology. 89 (1): 241–249. doi:10.1097/00000542-199807000-00030. PMID 9667313. Retrieved 2007-05-21. citing J. Arena, Poisoning: Toxicology-Symptoms-Treatments, 3rd edition. Springfield, Charles C. Thomas, 1974, p 345.</span></p></li><li id="quote_20"><span class="references-num">[20]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Szajewski J (1995). "Acute anticholinergic syndrome". IPCS Intox Databank. Archived from the original on 2 July 2007. Retrieved 2007-05-22..</span></p></li><li id="quote_21"><span class="references-num">[21]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Van der Meer, MJ; Hundt, HK; Müller, FO (October 1986). "The metabolism of atropine in man". The Journal of Pharmacy and Pharmacology. 38 (10): 781–4. PMID 2879005..</span></p></li><li id="quote_22"><span class="references-num">[22]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Rang, Dale, Ritter and More: Pharmacology, p. 139. Elsevier 2003..</span></p></li><li id="quote_23"><span class="references-num">[23]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Biography of Heinrich Friedrich Georg Mein (1799-1864) (in German)..</span></p></li><li id="quote_24"><span class="references-num">[24]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Heinrich Friedrich Georg Mein (1831) "Ueber die Darstellung des Atropins in weissen Kristallen" Archived 2016-05-15 at the Wayback Machine (On the preparation of atropine as white crystals), Annalen der Pharmacie, 6(1): 67-72..</span></p></li><li id="quote_25"><span class="references-num">[25]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Atropine was also independently isolated in 1833 by Geiger and Hesse: Geiger and Hesse (1833) "Darstellung des Atropins" Archived 2016-05-14 at the Wayback Machine (Preparation of atropine), Annalen der Pharmacie, 5: 43-81. Geiger and Hesse (1833) "Fortgesetzte Versuche über Atropin" Archived 2016-06-10 at the Wayback Machine (Continued experiments on atropine), Annalen der Pharmacie, 6: 44-65..</span></p></li><li id="quote_26"><span class="references-num">[26]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">See: Willstätter Richard (1901). "Synthese des Tropidins" [Synthesis of tropidine]. Berichte der Deutschen chemischen Gesellschaft zu Berlin. 34: 129–144. doi:10.1002/cber.19010340124. Archived from the original on 2013-03-01. Willstätter Richard (1901). "Umwandlung von Tropidin in Tropin" [Conversion of tropidine into tropine]. Berichte der Deutschen chemischen Gesellschaft zu Berlin. 34: 3163–3165. doi:10.1002/cber.190103402289. Archived from the original on 2013-01-26..</span></p></li><li id="quote_27"><span class="references-num">[27]</span><p><a class="ref-back-btn">^</a><span data-url="" class="">Dewick, Paul M. (2009). Medicinal natural products: A biosynthetic approach (3rd ed.). Chichester: A John Wiley &amp; Sons. ISBN 978-0470741672.</span></p></li></ul></div><div class="read-num">阅读 <!-- -->6028</div></div><div class="right-side" id="rightSide"><div class="side" id="lemma-side"><div class="side-title">版本记录</div><ul class="side-lst"><li><p class="side-lst-txt">暂无</p></li></ul><div class="user-card userCard"></div></div><div class="side"><div class="side-event"></div></div></div></div><div class="footer-box"><div id="footer"><div class="footer-logo-wrap"><div class="footer-logo"></div><div class="footer-logo-text">知识·传播·科普</div></div><div class="footer-info">本网站内容采用<a target="_blank" href="https://web.archive.org/web/20221028212154/https://creativecommons.org/licenses/by-sa/3.0/deed.zh?tdsourcetag=s_pctim_aiomsg">CC-BY-SA 3.0</a>授权</div><div class="footer-btn-wrap"><a target="_blank" href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/help/#user_protocol">用户协议</a><a target="_blank" href="https://web.archive.org/web/20221028212154/http://www.sogou.com/docs/terms.htm?v=1">免责声明</a><a target="_blank" href="https://web.archive.org/web/20221028212154/http://corp.sogou.com/private.html">隐私政策</a><a target="_blank" href="https://web.archive.org/web/20221028212154/https://baike.sogou.com/kexue/intro.htm">关于我们</a></div></div></div><script>window.lemmaInfo ={"lemmaId":"10046","versionId":"54548323545178633","title":"阿托品","subtitle":"","abstracts":{"paragraphId":"52067579929348363","title":"摘要","versionId":"52067579929348353","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330696,"comment":null,"dependVersionId":0,"contentType":2,"content":"<p>阿托品是一种药物，用于治疗特定类型的神经毒剂和农药中毒以及某些类型的心动过缓，并减少手术期间唾液的产生。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> 阿托品通常通过静脉注射或肌肉注射给药。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> 用于治疗葡萄膜炎和早期弱视的时候，它的滴眼液也是可行的。<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup> 静脉注射通常在一分钟内开始起效，药效持续半小时至1小时。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup> 可能需要大剂量来治疗一些中毒。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> </p>\n<p>阿托品常见的副作用包括口干、散瞳、尿潴留、便秘和心动过速。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> 该药物一般不用于闭角型青光眼患者。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> 没有证据表明在怀孕期间使用阿托品会导致出生缺陷，但是该领域还没有得到充分的研究。<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup> 在母乳期使用阿托品是基本安全的。<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup> 阿托品是一种抗毒蕈碱(一种抗胆碱能药)，通过抑制副交感神经系统发挥作用。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup> </p>\n<p>阿托品天然存在于茄属植物的许多植物中，包括致命的颠茄、曼陀罗草和曼德拉草。<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup> 1833年阿托品第一次被分离出来。<sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup> 现在它被列入世界卫生组织的基本药物清单，这些药物都是卫生系统中最有效和最安全的药物。<sup><a href=\"#quote_7\" class=\"kx_ref\">[7]</a></sup> 阿托品是一种普通的药物，而且比较廉价，在发展中国家，一毫克的小瓶阿托品批发价格在0.06美元到0.44美元之间。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},"card":{"paragraphId":"0","title":"","versionId":"0","lemmaId":0,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":0,"comment":null,"dependVersionId":0,"contentType":0,"content":"","pics":null,"card":null,"references":null,"versionCount":0},"categories":[{"id":3,"name":"化学","parents":[]}],"creator":{"uid":10145103,"name":"柚子otto","pic":"https://web.archive.org/web/20221028212154/https://img02.sogoucdn.com/app/a/200698/1152_1152_1864088_20200427232849-1518843971.png","introduction":"","educations":[{"schoolName":"中国地质大学（北京）","major":"","degree":"本科","universityId":22,"universityLogo":"https://web.archive.org/web/20221028212154/https://img01.sogoucdn.com/app/a/200943/d3465c1c-6011-11e9-b353-fc4dd4f70029","majorLevel1":"理学","majorLevel2":"地理学","majorLevel3":"地图学与地理信息系统","majorLevel1Id":1,"majorLevel2Id":103,"majorLevel3Id":109,"state":"毕业","lab":"","researchField":""}],"jobs":[{"company":"搜狗","title":"产品经理"}],"works":null,"educationBrief":"中国地质大学（北京）","jobBrief":"产品经理","role":0,"roleName":null,"title":"中国地质大学（北京） · 地理学本科","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":139,"partnerIdCreateTime":1595844881,"partnerIdPoped":true},"createTime":1571038190,"editor":{"uid":81910391,"name":"是福不是祸","pic":"https://web.archive.org/web/20221028212154/https://cache.soso.com/qlogo/g?b=oidb&k=6iaUd8ybMyWyTRyUPWibRsLg&s=100&t=1566664174","introduction":"全幼儿园最可爱的小朋友","educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":"","phoneNo":null,"editable":true,"partnerId":236,"partnerIdCreateTime":1596529271,"partnerIdPoped":true},"editTime":1598330696,"state":1,"versionCount":2,"upNum":2,"downNum":0,"pics":[{"originalUrl":"https://web.archive.org/web/20221028212154/https://img04.sogoucdn.com/app/a/200698/sogou_science_4365?w=300&h=225&titlename=%E4%B8%80%E7%A7%8D%E9%98%BF%E6%89%98%E5%93%81%E6%B3%A8%E5%B0%84%E6%B6%B2%E7%9A%84%E5%AE%89%E7%93%BF1mL%20/%200.5mg%E3%80%82","url":"https://web.archive.org/web/20221028212154/https://img04.sogoucdn.com/app/a/200698/sogou_science_4365","rw":300,"rh":225,"title":"一种阿托品注射液的安瓿1mL / 0.5mg。","alt":null,"width":0,"height":0},{"originalUrl":"https://web.archive.org/web/20221028212154/https://img02.sogoucdn.com/app/a/200698/sogou_science_4366?w=300&h=225&titlename=%E9%A2%A0%E8%8C%84","url":"https://web.archive.org/web/20221028212154/https://img02.sogoucdn.com/app/a/200698/sogou_science_4366","rw":300,"rh":225,"title":"颠茄","alt":null,"width":0,"height":0},{"originalUrl":"https://web.archive.org/web/20221028212154/https://img03.sogoucdn.com/app/a/200698/sogou_science_4367?w=300&h=188&titlename=%E4%BB%A5L-%E8%8B%AF%E4%B8%99%E6%B0%A8%E9%85%B8%E4%B8%BA%E8%B5%B7%E5%A7%8B%E5%8E%9F%E6%96%99%E5%90%88%E6%88%90%E9%98%BF%E6%89%98%E5%93%81","url":"https://web.archive.org/web/20221028212154/https://img03.sogoucdn.com/app/a/200698/sogou_science_4367","rw":300,"rh":188,"title":"以L-苯丙氨酸为起始原料合成阿托品","alt":null,"width":0,"height":0}],"catalogs":[{"level":1,"title":"医疗用途","paragraphId":"14994012352021000","subCatalogs":[{"level":2,"title":"眼睛","paragraphId":"14994012352021000","subCatalogs":null},{"level":2,"title":"心脏","paragraphId":"14994012352021000","subCatalogs":null},{"level":2,"title":"腺体分泌","paragraphId":"14994012352021000","subCatalogs":null},{"level":2,"title":"中毒","paragraphId":"14994012352021000","subCatalogs":null}]},{"level":1,"title":"副作用","paragraphId":"14994012352021001","subCatalogs":null},{"level":1,"title":"禁忌症","paragraphId":"14994012352021002","subCatalogs":null},{"level":1,"title":"化学结构","paragraphId":"14994012352021003","subCatalogs":null},{"level":1,"title":"药理作用","paragraphId":"14994012352021004","subCatalogs":null},{"level":1,"title":"历史发展","paragraphId":"14994012368798214","subCatalogs":null},{"level":1,"title":"自然资源","paragraphId":"14994012368798215","subCatalogs":null},{"level":1,"title":"综合","paragraphId":"14994012385575425","subCatalogs":[{"level":2,"title":"生物合成","paragraphId":"14994012385575425","subCatalogs":null}]},{"level":1,"title":"姓名","paragraphId":"14994012385575426","subCatalogs":null},{"level":1,"title":"参考文献","paragraphId":"-1","subCatalogs":null}],"paragraphs":[{"paragraphId":"14994012352021000","title":"医疗用途","versionId":"54548323545178634","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":82815118,"name":"iscience","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599809334,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p></p><h3>眼睛</h3><p></p><p>外用阿托品用作睫状肌麻痹剂，使调节反射暂时性麻痹，并用作散瞳剂，扩张瞳孔。阿托品代谢缓慢，通常在7<img alt=\"\" class=\"fileimage kx_img ed_imgfloat_right currentPic\" img_height=\"225\" img_width=\"300\" titlename=\"一种阿托品注射液的安瓿1mL / 0.5mg。\" data-src=\"https://img04.sogoucdn.com/app/a/200698/sogou_science_4365\">至14天内消失，通常作为散瞳剂，而托吡卡胺(一种短效胆碱拮抗剂)或去氧肾上腺素(一种α肾上腺素激动剂)则优选用于眼科检查。</p><p>在屈光性和调节性弱视中，当遮挡不合适时，阿托品可能会导致好的眼睛视力模糊。有证据表明在提高视力方面，阿托品在压抑疗法和遮盖疗法有同样的功效。<sup><a href=\"#quote_9\" class=\"kx_ref\">[9]</a></sup> </p><p>几项研究表明阿托品滴眼液能有效减缓儿童近视的发展，但目前还不能用于这种用途，副作用会限制其使用。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup> </p><p></p><h3>心脏</h3><p></p><p>阿托品注射用于治疗心动过缓(心率&lt; 60次/分钟)。</p><p>阿托品曾被纳入国际复苏指南，用于与心脏衰竭和PEA相关的心脏骤停，但由于缺乏有效证据，于2010年从该指南中删除。<sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup> 对于出现症状的心动过缓，通常剂量为0.5至1毫克静脉推注，可每3至5分钟重复一次，总剂量为3毫克(最大0.04毫克/千克)。<sup><a href=\"#quote_12\" class=\"kx_ref\">[12]</a></sup> </p><p>阿托品也可用于治疗二度莫氏1型房室传导阻滞(文氏阻滞)，以及具有高浦肯野或房室结逸搏节律的三级心脏传导阻滞。但是它对二度莫氏2型房室传导阻滞无效，对三级心脏传导阻滞伴有低浦肯野或心室逸搏节律无效。</p><p>阿托品也被用于预防儿童插管期间的心动过缓；然而，证据并不支持这种用法。<sup><a href=\"#quote_13\" class=\"kx_ref\">[13]</a></sup> </p><p></p><h3>腺体分泌</h3><p></p><p>阿托品通过对副交感神经系统作用抑制唾液腺和粘液腺。它还可以通过交感神经系统抑制出汗，这可以用于治疗多汗症，并可以防止垂死病人的死前喉鸣。尽管美国食品和药物管理局尚未正式指出阿托品可以用于上述用途，但医生已经为此目的开始使用阿托品。<sup><a href=\"#quote_14\" class=\"kx_ref\">[14]</a></sup> </p><p></p><h3>中毒</h3><p></p><p>阿托品不是有机磷中毒的真正解毒剂，但是阿托品通过阻断乙酰胆碱在M受体上的作用，可作为有机磷杀虫剂和神经毒气中毒的治疗药物，如塔崩、沙林、梭曼和VX。可能受到化学武器攻击的部队通常携带带有阿托品和肟类解毒剂的自动注射器，以便快速注射到大腿肌肉中，随着神经毒气中毒的发展，最大限度的阿托品化是可取的。使用时，阿托品经常与氯磷定一起使用。</p><p>一些神经毒剂通过磷酸化破坏乙酰胆碱酯酶，因此乙酰胆碱的作用变得过于持久，而解磷定(2-PAM)可以有效对抗有机磷中毒，因为它可以重新切断这种磷酸化。阿托品可以通过阻断M受体来降低中毒的影响，否则M受体会被乙酰胆碱的过度积累而刺激。</p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028212154/https://img04.sogoucdn.com/app/a/200698/sogou_science_4365?w=300&h=225&titlename=%E4%B8%80%E7%A7%8D%E9%98%BF%E6%89%98%E5%93%81%E6%B3%A8%E5%B0%84%E6%B6%B2%E7%9A%84%E5%AE%89%E7%93%BF1mL%20/%200.5mg%E3%80%82","url":"https://web.archive.org/web/20221028212154/https://img04.sogoucdn.com/app/a/200698/sogou_science_4365","rw":300,"rh":225,"title":"一种阿托品注射液的安瓿1mL / 0.5mg。","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012352021001","title":"副作用","versionId":"54548323545178635","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":82815118,"name":"iscience","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599809334,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>阿托品的不良反应包括心室颤动、室上性或室性心动过速、头晕、恶心、视力模糊、失去平衡、瞳孔放大、畏光、口干和潜在的严重失去意识、尤其在老年人群中，还易出现谵妄幻觉和兴奋。大多数安瓿装的阿托品都是硫酸盐的形式，阿托品的硫酸盐会导致组胺释放，并且使易感病人和对磺胺类药物过敏的病人出现过敏反应，后一种效应是因为阿托品能够穿过血脑屏障。由于存在致幻性，阿托品被一些人娱乐性质的使用，这存在着潜在的危险，而且经常引发矛盾。</p><p>过量服用阿托品是有毒的。阿托品有时被添加到潜在的成瘾性药物中，特别是止泻阿片类药物，如地芬诺酯或地芬诺辛，其中阿托品的抑制分泌作用也可有助于止泻。</p><p>虽然阿托品在紧急情况下治疗心动过缓(心率缓慢)，但当剂量非常低(即&lt; 0.5毫克)时，可能会导致反常的心率减慢<sup><a href=\"#quote_15\" class=\"kx_ref\">[15]</a></sup> 这可能是神经系统的中枢作用的结果。<sup><a href=\"#quote_16\" class=\"kx_ref\">[16]</a></sup> 阿托品在低剂量时产生反常心动过缓效应的一种机制是阻断抑制性突触前M受体，从而阻断抑制副交感神经反应的系统。<sup><a href=\"#quote_17\" class=\"kx_ref\">[17]</a></sup> </p><p>阿托品的剂量为每人10至20毫克，会使人丧失能力。它的LD50估计为每人453毫克(经口)，概率单位斜率为1.8。<sup><a href=\"#quote_18\" class=\"kx_ref\">[18]</a></sup> 阿托品的解毒剂是毒扁豆碱或毛果芸香碱。</p><p>描述阿托品过量的临床表现常用助记法是:\"热得像野兔，瞎得像蝙蝠，干得像骨头，红得像甜菜，疯得像帽匠\"。<sup><a href=\"#quote_19\" class=\"kx_ref\">[19]</a></sup> 这些联系反映了温暖干燥皮肤的特殊变化，如出汗减少、视力模糊、出汗/流泪减少、血管舒张和中枢神经系统对M受体4型和5型的影响。这一系列症状被称为抗胆碱中毒综合症，也可能由具有抗胆碱能作用的其他药物引起，如氢溴酸东莨菪碱(东莨菪碱)、苯海拉明、吩噻嗪抗精神病药物和苯妥英。<sup><a href=\"#quote_20\" class=\"kx_ref\">[20]</a></sup> </p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012352021002","title":"禁忌症","versionId":"54548323545178636","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":82815118,"name":"iscience","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599809334,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>阿托品禁用于预先治疗窄角型青光眼的患者。</p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012352021003","title":"化学结构","versionId":"54548323545178637","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":82815118,"name":"iscience","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599809334,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>阿托品是D-莨菪碱和L-莨菪碱的对映体混合物，其大部分生理作用来自于L-莨菪碱。其药理作用是由于阿托品与胆碱型乙酰胆碱受体结合，它是胆碱受体阻断药。在中枢神经系统中，药物浓度在30分钟至1小时内达到显著水平，然后迅速从血液中消失，半衰期为2小时。大约60%在尿液中以原型排出，其余大部分以水解和耦合产物的形式出现在尿液中。去甲阿托品(24%)、阿托品-氮氧化物(15%)、托品(2%)和托品酸(3%)是主要代谢物，而50%的服药量没有明显改变被排出，排出物没有检测到耦合产物。有证据发现阿托品以(+)-莨菪碱形式存在，这表明阿托品可能发生立体选择性代谢。<sup><a href=\"#quote_21\" class=\"kx_ref\">[21]</a></sup> 阿托品对虹膜和睫状肌的影响可能持续超过72小时。</p><p>药物中最常见的阿托品化合物是硫酸阿托品(一水合物)(C17H23NO3)2 H2SO4 H2O，全称是1α H，5αH-托品-3-α醇()-托品酯(酯)，硫酸盐一水合物。</p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012352021004","title":"药理作用","versionId":"54548323545178638","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":82815118,"name":"iscience","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599809334,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>一般来说，阿托品拮抗副交感神经系统调节的腺体的“休息和消化”活动。这是因为阿托品是胆碱型乙酰胆碱受体(乙酰胆碱是副交感神经系统的主要神经递质)的竞争性可逆拮抗剂。</p><p>阿托品是胆碱型乙酰胆碱受体类型M1、M2、M3、M4和M5的竞争性拮抗剂。<sup><a href=\"#quote_22\" class=\"kx_ref\">[22]</a></sup> 它被归类为胆碱受体阻断药(副交感神经阻断药)。</p><p>在心脏应用中，它作为非选择性胆碱型乙酰胆碱拮抗剂发挥作用，增加窦房结的触发和通过心脏房室结的传导，拮抗迷走神经的作用，阻断乙酰胆碱受体位点，并减少支气管分泌物。</p><p>在眼部，阿托品通过阻断圆形瞳孔括约肌收缩产生散瞳作用，进而使桡动脉虹膜扩张肌收缩并散瞳，圆形瞳孔括约肌通常是乙酰胆碱释放产生刺激作用。阿托品可以麻痹睫状肌，睫状肌的作用是抑制儿童进行精确屈光调节，有助于减轻虹膜睫状体炎相关的疼痛，并治疗睫状体阻塞(恶性)青光眼。</p><p>迷走神经释放乙酰胆碱作为心脏的主要神经递质，乙酰胆碱与M受体(M2)结合，M受体主要存在于窦房结和房室结细胞中，而M受体与Gi蛋白偶联；因此，迷走神经激活降低了cAMP（环磷酸腺苷）。Gi蛋白激活也导致钾离子通道的激活，增加钾离子的流出并使细胞超极化。</p><p>迷走神经对窦房结活动的增加降低了起搏电位的斜率(动作电位的第4阶段)同时也降低起搏细胞的放电率，也降低了心率(负心律变率性)。阶段4斜率的变化是由钾离子电流和钙离子电流的变化，以及缓慢内流的钠离子电流，它被认为是起搏电流产生的原因。通过使细胞超极化，迷走神经的活化增加了细胞的放电阈值，这有助于降低放电速率。房室结也有类似的电生理效应；然而，在这种组织中，这些变化表现为通过房室结的脉冲传导速度降低(负向单向传导)。在静息状态下，心脏有很大程度的迷走神经张力，这是静息心率低的原因。</p><p>心房肌肉也有一些迷走神经的神经支配，心室肌肉则更少。因此，迷走神经活化导致心房收缩力(收缩力)的适度降低，甚至心室收缩力的更小的降低。</p><p>M受体拮抗剂结合M受体，从而防止ACh结合并激活受体。M受体拮抗剂通过阻断ACh的作用，非常有效地阻断迷走神经活动对心脏的影响。通过这样，他们增加了心率和传导速度。</p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012368798214","title":"历史发展","versionId":"52067579929348359","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330696,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><img alt=\"\" class=\"fileimage kx_img ed_imgfloat_right\" img_height=\"225\" img_width=\"300\" titlename=\"颠茄\" data-src=\"https://img02.sogoucdn.com/app/a/200698/sogou_science_4366\"> </p><p>曼陀罗(曼德拉草)在公元前四世纪被提奥夫拉斯图斯记录为治疗伤口、痛风和失眠的药物，以及爱情药剂。到公元一世纪，迪奥斯科林斯认为曼德拉草酒是一种麻醉剂，用于治疗疼痛或失眠，在手术或烧灼术之前服用。含有托烷生物碱的茄科经常与鸦片结合用于麻醉，在整个罗马帝国和伊斯兰帝国时期一直存在，并在欧洲也持续存在，直到被乙醚、氯仿和其他现代麻醉剂所取代。</p><p>埃及克娄巴特拉在公元前最后一个世纪使用埃及天仙子中提取的阿托品扩大她的瞳孔，希望她看起来更有魅力。在文艺复兴时期，出于对美丽的原因，女性使用阿特拉巴贝拉当纳的浆果汁来扩大她们的瞳孔。这种做法在十九世纪末二十世纪初在巴黎曾短暂地恢复。</p><p>德国化学家弗里德利布·费迪南·龙格(1795-1867)研究了阿托品的散瞳效应。1831年，德国药剂师海因里希·梅因(1799-1864)<sup><a href=\"#quote_23\" class=\"kx_ref\">[23]</a></sup> 成功地制备出阿托品晶体。<sup><a href=\"#quote_24\" class=\"kx_ref\">[24]</a></sup> <sup><a href=\"#quote_25\" class=\"kx_ref\">[25]</a></sup> 1901年，德国化学家理查德·威尔斯特首次合成了这种物质。<sup><a href=\"#quote_26\" class=\"kx_ref\">[26]</a></sup> </p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028212154/https://img02.sogoucdn.com/app/a/200698/sogou_science_4366?w=300&h=225&titlename=%E9%A2%A0%E8%8C%84","url":"https://web.archive.org/web/20221028212154/https://img02.sogoucdn.com/app/a/200698/sogou_science_4366","rw":300,"rh":225,"title":"颠茄","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012368798215","title":"自然资源","versionId":"54548323545178639","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":82815118,"name":"iscience","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599809334,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>阿托品存在于茄科的许多成员中。最常见的来源是颠茄、曼陀罗、金雀花和曼陀罗。其他来源包括木曼陀罗属和天仙子属的成员。</p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012385575425","title":"综合","versionId":"52067579929348361","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":81910391,"name":"哈哈","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1598330696,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>阿托品可以在盐酸存在下由莨菪碱与托品酸反应合成。</p><p></p><h3>生物合成</h3><p></p><p><img alt=\"\" class=\"fileimage kx_img ed_imgfloat_right\" img_height=\"188\" img_width=\"300\" titlename=\"以L-苯丙氨酸为起始原料合成阿托品\" data-src=\"https://img03.sogoucdn.com/app/a/200698/sogou_science_4367\"> </p><p>从l-苯丙氨酸开始的阿托品生物合成首先经历转氨作用，形成苯丙酮酸，然后被还原成苯乳酸。辅酶a然后将苯基乳酸与托品偶联形成利特林，然后托品经历由P450酶引发的自由基重排形成天仙子胺醛。脱氢酶随后将醛还原成伯醇，生成()-天仙子胺，在外消旋化时形成阿托品。<sup><a href=\"#quote_27\" class=\"kx_ref\">[27]</a></sup> </p>","pics":[{"originalUrl":"https://web.archive.org/web/20221028212154/https://img03.sogoucdn.com/app/a/200698/sogou_science_4367?w=300&h=188&titlename=%E4%BB%A5L-%E8%8B%AF%E4%B8%99%E6%B0%A8%E9%85%B8%E4%B8%BA%E8%B5%B7%E5%A7%8B%E5%8E%9F%E6%96%99%E5%90%88%E6%88%90%E9%98%BF%E6%89%98%E5%93%81","url":"https://web.archive.org/web/20221028212154/https://img03.sogoucdn.com/app/a/200698/sogou_science_4367","rw":300,"rh":188,"title":"以L-苯丙氨酸为起始原料合成阿托品","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"14994012385575426","title":"姓名","versionId":"54548323545178640","lemmaId":10046,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":82815118,"name":"iscience","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1599809334,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>物种名称“颠茄”(意大利语中的“美丽女人”)来源于最初使用的茄属植物来扩张瞳孔以达到美容效果。阿托品和颠茄的属名都来源于阿特洛波斯，根据希腊神话，他是选择一个人死亡方式的命运三神之一。</p>","pics":null,"card":null,"references":[],"versionCount":0}],"references":[{"id":1,"type":"book","title":"\"Atropine\". The American Society of Health-System Pharmacists. Archived from the original on 2015-07-12. Retrieved Aug 13, 2015.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":2,"type":"book","title":"design, Richard J. Hamilton ; Nancy Anastasi Duffy, executive editor ; Daniel Stone, production editor ; Anne Spencer, cover (2014). Tarascon pharmacopoeia (15 ed.). p. 386. ISBN 9781284056716. Archived from the original on 2015-10-02.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":3,"type":"book","title":"Barash, Paul G. (2009). Clinical anesthesia (6th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. p. 525. ISBN 9780781787635. Archived from the original on 2015-11-24.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":4,"type":"book","title":"\"Atropine Pregnancy and Breastfeeding Warnings\". Archived from the original on 6 September 2015. Retrieved 14 August 2015.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":5,"type":"book","title":"Brust,, John C. M. (2004). Neurological aspects of substance abuse (2 ed.). Philadelphia: Elsevier. p. 310. ISBN 9780750673136. Archived from the original on 2015-10-02.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":6,"type":"book","title":"Ainsworth, Sean (2014). Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. John Wiley & Sons. p. 94. ISBN 9781118819593. Archived from the original on 2015-10-02.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":7,"type":"book","title":"\"WHO Model List of Essential Medicines (19th List)\" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":8,"type":"book","title":"\"Atropine Sulfate\". International Drug Price Indicator Guide. Retrieved 13 August 2015.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":9,"type":"book","title":"Li T, Shotton K (2009). \"Conventional occlusion versus pharmacologic penalization for amblyopia\". Cochrane Database Syst Rev. 4: CD006460. doi:10.1002/14651858.CD006460.pub2. PMC 3804306. PMID 19821369.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":10,"type":"book","title":"Walline JJ, Lindsley K, Vedula SS, Cotter SA, Mutti DO, Twelker JD (2011). \"Interventions to slow progression of myopia in children\". Cochrane Database Syst Rev (12): CD004916. doi:10.1002/14651858.CD004916.pub3. PMC 4270373. PMID 22161388.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":11,"type":"book","title":"Field JM, Hazinski MF, Sayre MR, et al. (November 2010). \"Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care\". Circulation. 122 (18 Suppl 3): S640–56. doi:10.1161/CIRCULATIONAHA.110.970889. PMID 20956217. Archived from the original on 2010-11-14.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":12,"type":"book","title":"* Bryan E, Bledsoe; Robert S. Porter; Richard A. Cherry (2004). \"Ch. 3\". Intermediate Emergency Care. Upper Saddle River, NJ: Pearson Prentice Hill. p. 260. ISBN 0-13-113607-0.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":13,"type":"book","title":"de Caen, AR; Berg, MD; Chameides, L; Gooden, CK; Hickey, RW; Scott, HF; Sutton, RM; Tijssen, JA; Topjian, A; van der Jagt, ÉW; Schexnayder, SM; Samson, RA (3 November 2015). \"Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care\" (PDF). Circulation. 132 (18 Suppl 2): S526–42. doi:10.1161/cir.0000000000000266. PMID 26473000.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":14,"type":"book","title":"Death Rattle and Oral Secretions Archived 2014-04-14 at the Wayback Machine","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":15,"type":"book","title":"\"Archived copy\". Archived from the original on 2014-02-20. Retrieved 2014-02-02.CS1 maint: Archived copy as title (link)","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":16,"type":"book","title":"* Rang HP, Dale MM, Ritter JM, Flower RJ (2007). \"Ch. 10\". Rang and Dale's Pharmacology. Elsevier Churchill Livingstone. p. 153. ISBN 0-443-06911-5.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":17,"type":"book","title":"Laurence, Brunton (2010). Goodman & Gilman's Pharmacological Basis of Therapeutics, 12th Edition. McGraw-Hill. ISBN 978-0-07-162442-8.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":18,"type":"book","title":"* Goodman E (2010). Ketchum J, Kirby R, eds. Historical Contributions to the Human Toxicology of Atropine. Eximdyne. p. 120. ISBN 978-0-9677264-3-4.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":19,"type":"book","title":"Robert S. Holzman, MD (July 1998). \"The Legacy of Atropos\". Anesthesiology. 89 (1): 241–249. doi:10.1097/00000542-199807000-00030. PMID 9667313. Retrieved 2007-05-21. citing J. Arena, Poisoning: Toxicology-Symptoms-Treatments, 3rd edition. Springfield, Charles C. Thomas, 1974, p 345","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":20,"type":"book","title":"Szajewski J (1995). \"Acute anticholinergic syndrome\". IPCS Intox Databank. Archived from the original on 2 July 2007. Retrieved 2007-05-22.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":21,"type":"book","title":"Van der Meer, MJ; Hundt, HK; Müller, FO (October 1986). \"The metabolism of atropine in man\". The Journal of Pharmacy and Pharmacology. 38 (10): 781–4. PMID 2879005.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":22,"type":"book","title":"Rang, Dale, Ritter and More: Pharmacology, p. 139. Elsevier 2003.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":23,"type":"book","title":"Biography of Heinrich Friedrich Georg Mein (1799-1864) (in German).","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":24,"type":"book","title":"Heinrich Friedrich Georg Mein (1831) \"Ueber die Darstellung des Atropins in weissen Kristallen\" Archived 2016-05-15 at the Wayback Machine (On the preparation of atropine as white crystals), Annalen der Pharmacie, 6(1): 67-72.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":25,"type":"book","title":"Atropine was also independently isolated in 1833 by Geiger and Hesse: Geiger and Hesse (1833) \"Darstellung des Atropins\" Archived 2016-05-14 at the Wayback Machine (Preparation of atropine), Annalen der Pharmacie, 5: 43-81. Geiger and Hesse (1833) \"Fortgesetzte Versuche über Atropin\" Archived 2016-06-10 at the Wayback Machine (Continued experiments on atropine), Annalen der Pharmacie, 6: 44-65.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":26,"type":"book","title":"See: Willstätter Richard (1901). \"Synthese des Tropidins\" [Synthesis of tropidine]. Berichte der Deutschen chemischen Gesellschaft zu Berlin. 34: 129–144. doi:10.1002/cber.19010340124. Archived from the original on 2013-03-01. Willstätter Richard (1901). \"Umwandlung von Tropidin in Tropin\" [Conversion of tropidine into tropine]. Berichte der Deutschen chemischen Gesellschaft zu Berlin. 34: 3163–3165. doi:10.1002/cber.190103402289. Archived from the original on 2013-01-26.","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":27,"type":"book","title":"Dewick, Paul M. (2009). Medicinal natural products: A biosynthetic approach (3rd ed.). Chichester: A John Wiley & Sons. ISBN 978-0470741672","site":"","url":"","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false}],"recommendReferences":null,"auditState":2,"lemmaLevel":1,"origin":0,"originEnTitle":null,"originZhTitle":null,"pv":6028,"auditType":2,"synonyms":["Atropine","Atropinol","Borotropin"],"showEditTime":"2020.08.25 12:44","auditors":[{"uid":5567290,"name":"人间小太阳","pic":"https://web.archive.org/web/20221028212154/https://cache.soso.com/qlogo/g?b=oidb&k=4xjGfuUZbbjZEI7OAVIVEg&s=100&t=1609215301","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":250,"partnerIdCreateTime":1598322359,"partnerIdPoped":true}],"hasZhishiNav":true,"auditInfos":{"0":[{"versionId":"0","auditTime":1598337277,"auditorId":5567290,"auditUser":{"uid":5567290,"name":"人间小太阳","pic":"https://web.archive.org/web/20221028212154/https://cache.soso.com/qlogo/g?b=oidb&k=4xjGfuUZbbjZEI7OAVIVEg&s=100&t=1609215301","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":250,"partnerIdCreateTime":1598322359,"partnerIdPoped":true},"auditReason":"","auditSuggest":"简单修改","auditResult":2,"auditAnnotations":null}]},"isHistory":false};</script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/aegis.min.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/main_2020092401.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/jquery-1.11.1.min.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/main_2022062701.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/main_66bbe21.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/react.production.min.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/react-dom.production.min.js.download"></script><script crossorigin="anonymous" src="./46.阿托品 - 搜狗科学百科_files/main_edf0f08.js.download"></script><div id="popControl"><div class="pop-control-mask" style="display: none;"><div class="pop-container"><i class="close-icon"></i><div class="stop-title">搜狗科学百科停止服务运营公告</div><div class="stop-user">亲爱的用户：</div><div class="stop-content">因业务方向调整，搜狗科学百科将于2022年11月11日正式停止服务与运营。届时产品内所有数据将依据相关法律进行删除并关闭服务器，您将无法登录及使用搜狗科学百科，相关内容在平台下线后将无法找回。</div><div class="stop-content">搜狗科学百科是由搜狗推出的科学领域专业百科产品，与搜狗百科为两个独立产品，本次停止服务与运营仅对搜狗科学百科，并不影响搜狗百科产品正常使用，敬请知悉。</div><div class="stop-content">由此给您带来的不便我们深表歉意，敬请谅解。再次感谢您一直以来的陪伴与支持！</div><div class="stop-team">搜狗科学百科产品&amp;运营团队</div><div class="stop-time">2022年10月11日</div></div></div></div>
<source>document.getElementById('popControl').style.display = 'none'; </source>
</body></html>